Em Nasdaq a AAII já desce 36,52 (até já desceu 40%)...tudo por causa disto:
WILMINGTON, N.C., March 1 /PRNewswire-FirstCall/ -- The Board of Directors of aaiPharma Inc. (Nasdaq: AAII) announced that subsequent to the issuance of the Company's press release announcing its 2003 financial results and in connection with the recently announced reorganization of the Company's management team, the Board of Directors has become aware of unusual sales in the Company's Brethine(R) and Darvocet(TM) product lines during the second half of 2003. The Company has appointed an independent committee of its Board of Directors to conduct an inquiry into these matters. The committee has retained King & Spalding LLP, an independent law firm, to assist in this investigation. The Company believes these matters will materially affect its previously announced guidance for the first quarter and full year of 2004 and is withdrawing its guidance for these periods, and these matters may, depending on the results of the inquiry, require an adjustment to the 2003 financial results.
Dr. Frederick D. Sancilio, Chairman of the Board of Directors, indicated that "the Company will not comment further on these matters until the independent inquiry has been concluded. We do not presently know how long this process will take, and in light of the March 15 filing deadline, this process could delay the filing of the Company's 2003 annual report on Form 10-K."
O Clubeinvest.com informa que nenhuma da informação
aqui facultada deverá ser entendida como conselho ou recomendação
de qualquer tipo de transacção ou investimento.
